BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Sarah Cannon Research Institute Expands into East Tennessee Through Collaboration with Tennessee Cancer Specialists

  Sarah Cannon Research Institute announced a collaboration with Tennessee Cancer Specialists, an independent, private practice oncology group, based in Knoxville, Tenn.

  May 23, 2024

   · 

  3 min read
• Emergence Of CD19 Targeted Antibodies

  CD19, a protein prominently displayed on the surface of B cells, has become a focal point in therapeutic interventions for a spectrum of diseases, particularly cancer.

  May 23, 2024

   · 

  2 min read
• CDC 7 Kinase Inhibitor Clinical Landscape

  Over the past three decenniums, the perception to treat cancer malignancies has improved from the time when the scientist and researches discovered the idea of inhibitors.

  May 23, 2024

   · 

  4 min read
• U.S. Biotechnology Instruments Market Size to Reach USD 49.11 Bn by 2033

  According to latest study, the U.S. biotechnology instruments market size is calculated at USD 36.16 billion for 2024 and is expected to reach around USD 49.11 billion by 2033, growing at a CAGR of 3.46% from 2024 to 2033.

  May 23, 2024

   · 

  1 min read
• Bio NC

  Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients Honored for Notable Biopharmaceutical Industry Impact

  Syneos Health® announced PM360 has named six distinguished colleagues as recipients of its 10th Annual ELITE 100 Awards.

  May 23, 2024

   · 

  3 min read
• Lexaria Awards Contract For Third GLP-1 Human Pilot Study

  Lexaria Bioscience Corp., a global innovator in drug delivery platforms announces it has hired a contract research organization to perform the Company’s human pilot study #3, which will evaluate a dual action GLP-1 + GIP.

  May 23, 2024

   · 

  5 min read
• Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024

  On May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal cell carcinoma in an oral presentation at the 27th Annual Meeting of the American Society for Gene & Cell Therapy in Baltimore.

  May 23, 2024

   · 

  3 min read
• BioMidwest

  Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC)

  Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine Accelerating Medicines Partnership Bespoke Gene Therapy Consortium.

  May 23, 2024

   · 

  3 min read
• Drug Development

  Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

  Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd., announced encouraging initial findings from an ongoing Phase 1 clinical trial.

  May 23, 2024

   · 

  9 min read
• BioMidwest

  Medline introduces high-efficiency medication delivery system to respiratory portfolio

  Medline announced the latest addition to its respiratory care portfolio, the Hudson RCI TurboMist small volume nebulizer.

  May 23, 2024

   · 

  3 min read